Market Overview:
The global female contraceptive market is expected to register a CAGR of 7.5% during the forecast period, 2018-2030. The market growth can be attributed to the increasing awareness about contraception and family planning methods among women, rising prevalence of sexually transmitted infections (STIs), and technological advancements in female contraceptive devices. Based on type, the global female contraceptive market is segmented into female contraceptive devices and female contraceptive drugs. Female contraceptive devices are further classified into barrier methods, hormonal methods, intrauterine devices (IUDs), and other devices. Hormonal methods are further sub-segmented into oral contraceptives (OCPs) and injectable contraceptives. Female contraceptive drugs are sub-segmented into emergency contraception pills (ECPs) and long-term contraception pills (LTCPs). Barrier methods accounted for the largest share of the global female condom market in 2017 owing to their high adoption rates across regions. However, hormonal contraceptives are expected to witness highest growth during the forecast period due to their advantages such as ease of use, fewer side effects compared with other types of contraceptives, and longer duration of action than barrier methods.
Product Definition:
A female contraceptive is a method of preventing pregnancy in women. Female contraceptives work by stopping the release of an egg from the ovaries, or by keeping sperm from reaching the eggs. There are many different types of female contraceptives, including birth control pills, patches, rings, implants, and injections.
Female Contraceptive Devices:
The female contraceptive devices market is expected to grow at a lucrative rate during the forecast period. The factors that propel the growth of this industry are increasing awareness about sexual health and family planning, rising demand for long-term reversible contraception, technological advancements in terms of drug delivery systems and new product development by major players.
Female Contraceptive Drugs:
The female contraceptive drugs market is expected to grow at a lucrative rate during the forecast period. The factors that propel the growth of this industry are increasing awareness about family planning, rising population of women in their reproductive years, and demand for cost-effective products.
According to United Nations Department of Economic and Social Affairs (2015), global population is 7.3 billion which includes 2 billion women and children under the age of 15 years.
Application Insights:
Online stores held the largest share of over 60.0% in 2017. This is attributed to the growing use of online shopping as a mode for family planning by women across the globe, especially in developing countries such as India and China. Moreover, e-commerce players have been working roundtheclock to fulfill orders and meet customer expectations which has increased their market share among other outlets worldwide.
The retail outlets segment is expected to witness significant growth over the forecast period owing to rising awareness about availability of contraceptives at local stores or pharmacies that are easily accessible for customers without requiring an appointment or medical consultation hours.
Regional Analysis:
North America dominated the global female contraceptive market in 2017. This can be attributed to rising awareness about various contraceptives, high purchasing power parity, and availability of a wide range of products. Moreover, increasing demand for long-term contraception is also expected to drive the North American market over the forecast period.
Asia Pacific is estimated to be the fastest growing regional market from 2018 to 2030 owing to a rise in population and awareness about modern contraceptives among women in this region.
Growth Factors:
- Increasing awareness about contraception and its benefits
- Rise in number of women in the workforce
- Growing acceptance of contraception among young couples
- Government initiatives to promote contraceptive use among women
- Increased focus on sexual and reproductive health
Scope Of The Report
Report Attributes
Report Details
Report Title
Female Contraceptive Market Research Report
By Type
Female Contraceptive Devices, Female Contraceptive Drugs
By Application
Online Stores, Retail Outlets
By Companies
Merck, Pfizer, Allergan, Bayer, Okamoto Industries, Reckitt Benckiser, Lupin Pharmaceuticals, Foundation Consumer Healthcare, Teva Pharmaceuticals, Ansell, Merck, Fuji Latex, Janssen Pharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
195
Number of Tables & Figures
137
Customization Available
Yes, the report can be customized as per your need.
Global Female Contraceptive Market Report Segments:
The global Female Contraceptive market is segmented on the basis of:
Types
Female Contraceptive Devices, Female Contraceptive Drugs
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Online Stores, Retail Outlets
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Merck
- Pfizer
- Allergan
- Bayer
- Okamoto Industries
- Reckitt Benckiser
- Lupin Pharmaceuticals
- Foundation Consumer Healthcare
- Teva Pharmaceuticals
- Ansell
- Merck
- Fuji Latex
- Janssen Pharmaceuticals
Highlights of The Female Contraceptive Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Female Contraceptive Devices
- Female Contraceptive Drugs
- By Application:
- Online Stores
- Retail Outlets
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Female Contraceptive Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Female contraceptive methods are any means of preventing pregnancy that a woman uses alone. These methods can be effective for many years, depending on the method used. Some female contraceptives include using birth control pills, condoms, diaphragms and spermicides.
Some of the key players operating in the female contraceptive market are Merck, Pfizer, Allergan, Bayer, Okamoto Industries, Reckitt Benckiser, Lupin Pharmaceuticals, Foundation Consumer Healthcare, Teva Pharmaceuticals, Ansell, Merck, Fuji Latex, Janssen Pharmaceuticals.
The female contraceptive market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Female Contraceptive Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Female Contraceptive Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Female Contraceptive Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Female Contraceptive Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Female Contraceptive Market Size & Forecast, 2020-2028 4.5.1 Female Contraceptive Market Size and Y-o-Y Growth 4.5.2 Female Contraceptive Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Female Contraceptive Devices
5.2.2 Female Contraceptive Drugs
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Online Stores
6.2.2 Retail Outlets
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Female Contraceptive Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Female Contraceptive Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Female Contraceptive Devices
9.6.2 Female Contraceptive Drugs
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Online Stores
9.10.2 Retail Outlets
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Female Contraceptive Devices
10.6.2 Female Contraceptive Drugs
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Online Stores
10.10.2 Retail Outlets
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Female Contraceptive Devices
11.6.2 Female Contraceptive Drugs
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Online Stores
11.10.2 Retail Outlets
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Female Contraceptive Devices
12.6.2 Female Contraceptive Drugs
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Online Stores
12.10.2 Retail Outlets
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Female Contraceptive Devices
13.6.2 Female Contraceptive Drugs
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Online Stores
13.10.2 Retail Outlets
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Female Contraceptive Market: Competitive Dashboard
14.2 Global Female Contraceptive Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Merck
14.3.2 Pfizer
14.3.3 Allergan
14.3.4 Bayer
14.3.5 Okamoto Industries
14.3.6 Reckitt Benckiser
14.3.7 Lupin Pharmaceuticals
14.3.8 Foundation Consumer Healthcare
14.3.9 Teva Pharmaceuticals
14.3.10 Ansell
14.3.11 Merck
14.3.12 Fuji Latex
14.3.13 Janssen Pharmaceuticals